SMARCA2 and pancreatic adenocarcinoma: We employed a human pancreatic adenocarcinoma cell line, MiaPaCa-2, which contains the SWI/SNF ATPase BRG1, but lacks BRM, and HeLa cells that express both BRM and BRG1.